Cutia Therapeutics（Wuxi）Co.,Ltd

2 in Phase 3

Quick facts

Phase 3 pipeline

CU-40102 Spray · Dermatology
CU-40102 is a topical spray formulation designed to treat skin conditions, likely through local delivery of an active pharmaceutical ingredient to affected areas.
Lidocaine tetracaine cream · Dermatology
Lidocaine and tetracaine are local anesthetics that block sodium channels in nerve cell membranes to inhibit pain signal transmission.

Phase 2 pipeline

Subcutaneous injection of CU-20401

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Cutia Therapeutics（Wuxi）Co.,Ltd

What is Cutia Therapeutics（Wuxi）Co.,Ltd's pipeline?

Cutia Therapeutics（Wuxi）Co.,Ltd has 2 drugs in Phase 3, 1 in Phase 2, 4 in Phase 1. Late-stage candidates include CU-40102 Spray, Lidocaine tetracaine cream.

Sector hub: All tracked pharma companies